Hoxton Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$73K Buy
1,150
+205
+22% +$12.9K 0.04% 128
2015
Q4
$65K Hold
945
0.03% 118
2015
Q3
$56K Buy
945
+400
+73% +$25.4K 0.03% 132
2015
Q2
$36K Hold
545
0.01% 153
2015
Q1
$35K Hold
545
0.01% 150
2014
Q4
$32K Hold
545
0.01% 156
2014
Q3
$28K Hold
545
0.01% 156
2014
Q2
$26K Hold
545
0.01% 163
2014
Q1
$28K Buy
+545
New +$29K 0.01% 157

Other funds holding BMY

Hoxton Financial's BMY Position: Q1 2016 in Review

Hoxton Financial increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2016, buying an estimated $12.9K and bringing the position to 1,150 shares worth $73K. The position accounts for 0.04% of the portfolio, ranked #128.

Hoxton Financial first reported a position in BMY in Q1 2014 and has held it in 9 quarters since. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Hoxton Financial held 1,150 shares of Bristol-Myers Squibb worth $73K as of Q1 2016.
  • Hoxton Financial bought 205 Bristol-Myers Squibb shares in Q1 2016, an estimated $12.9K.
  • Bristol-Myers Squibb made up 0.04% of Hoxton Financial's portfolio in Q1 2016, its #128 holding.
  • Hoxton Financial first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 9 quarters since.
  • 1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.